Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Healthcare ETF

70.35
-0.3292-0.47%
Volume:95.62K
Turnover:6.72M
Market Cap:3.65B
PE:6.34
High:70.71
Open:70.71
Low:70.08
Close:70.68
52wk High:74.59
52wk Low:56.44
Shares:51.90M
Float Shares:51.90M
Volume Ratio:0.93
T/O Rate:0.18%
Dividend:0.80
Dividend Rate:1.14%
EPS(TTM):11.10
EPS(LYR):3.06
ROE:6.01%
ROA:0.87%
PB:1.30
PE(LYR):23.00

Loading ...

U.S. Stocks on the MOVE-US Energy Stocks, Baldwin, Johnson & Johnson

Reuters
·
Yesterday

J&J - Jnj Reports Rybrevant Plus Chemotherapy Extends Pfs2 by 10.8 Months in Nsclc

THOMSON REUTERS
·
Yesterday

Johnson & Johnson’s Rybrevant® (Amivantamab-Vmjw) Plus Chemotherapy Delivers Longest Reported Median Overall Survival in Egfr Exon 20 Insertion Mutation-Positive Lung Cancer

THOMSON REUTERS
·
Yesterday

J&J - Jnj Reports no New Safety Signals for Rybrevant Plus Chemotherapy in Nsclc Study

THOMSON REUTERS
·
Yesterday

Scholar Rock Wins FDA Approval for SMA Therapy

TIPRANKS
·
Yesterday

Potential Buyer Emerges for Johnson & Johnson's Orthopedics Unit

Deep News
·
Yesterday

Scholar Rock price target raised to $84 from $76 at BMO Capital

TIPRANKS
·
Yesterday

Perspective Therapeutics Enters Cancer Clinical Trial Collaboration With Merck; Shares Up Pre-Bell

MT Newswires Live
·
Yesterday

Perspective Therapeutics Partners with Merck to Test [212Pb]PSV359 with Keytruda in FAP-Α-Positive Solid Tumors

Reuters
·
Yesterday

Perspective Therapeutics, - Co Sponsors Study; Merck Provides Pembrolizumab at no Cost

THOMSON REUTERS
·
Yesterday

Johnson & Johnson reports PAPILLON study meets primary endpoint

TIPRANKS
·
Yesterday

Market Chatter: Apollo Global in Talks to Buy J&J Orthopedics Unit for $20 Billion

MT Newswires Live
·
Yesterday

One State's Battle to Stop People from Taking Unapproved Weight-Loss Drugs

Dow Jones
·
Yesterday

Nanobiotix announces updated safety, efficacy data from JNJ-1900 study

TIPRANKS
·
Yesterday

Johnson & Johnson Says Lung Cancer Drug Combination Extends Median Survival to Over 34 Months

MT Newswires Live
·
Yesterday

J&J Shares up 1.2% Premarket After Report Co's Orthopedics Unit Draws Apollo Interest in Potential $20 Bln Deal

THOMSON REUTERS
·
Yesterday

Big Pharma is Pouring Billions into China's Biotechs

Dow Jones
·
Yesterday

Dow Jones Top Company Headlines at 1 am ET: Biggest AI Rivals Agree They Need to Slow it Down | Amazon ...

Dow Jones
·
Yesterday

J&J - Rybrevant Plus Chemotherapy Delivers Longest Reported Median Overall Survival in Egfr Exon 20 Insertion Nsclc

THOMSON REUTERS
·
Yesterday

Dow Jones Top Company Headlines at 9 PM ET: Amazon Pauses Operations with 21 Air After Miami Crash | Pfizer ...

Dow Jones
·
Yesterday